rs141873745
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_024422.6(DSC2):c.2603C>T(p.Ser868Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,968 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.2603C>T | p.Ser868Phe | missense_variant | Exon 16 of 16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_001406506.1 | c.2174C>T | p.Ser725Phe | missense_variant | Exon 16 of 16 | NP_001393435.1 | ||
DSC2 | NM_004949.5 | c.*105C>T | 3_prime_UTR_variant | Exon 17 of 17 | NP_004940.1 | |||
DSC2 | NM_001406507.1 | c.*105C>T | 3_prime_UTR_variant | Exon 17 of 17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.2603C>T | p.Ser868Phe | missense_variant | Exon 16 of 16 | 1 | NM_024422.6 | ENSP00000280904.6 | ||
DSC2 | ENST00000251081 | c.*105C>T | 3_prime_UTR_variant | Exon 17 of 17 | 1 | ENSP00000251081.6 | ||||
DSC2 | ENST00000648081.1 | c.2174C>T | p.Ser725Phe | missense_variant | Exon 17 of 17 | ENSP00000497441.1 | ||||
DSC2 | ENST00000682357.1 | c.2174C>T | p.Ser725Phe | missense_variant | Exon 16 of 16 | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152042Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251236Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135772
GnomAD4 exome AF: 0.0000540 AC: 79AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.0000701 AC XY: 51AN XY: 727200
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74396
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individual with arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy (DCM) and sudden cardiac death; however, some of these individuals also harbored variants in other cardiomyopathy-related genes (PMID: 36178741, 26498160, 20400443, 27930701, 31970460); This variant is associated with the following publications: (PMID: 30790397, 20400443, 27930701, 31970460, 36178741, 26498160) -
- -
Arrhythmogenic right ventricular dysplasia 11 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 868 of the DSC2 protein (p.Ser868Phe). This variant is present in population databases (rs141873745, gnomAD 0.01%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy and/or sudden death (PMID: 20400443, 26498160, 27930701, 30790397, 31970460). ClinVar contains an entry for this variant (Variation ID: 427964). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces serine with phenylalanine at codon 868 of the DSC2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20400443, 30790397). Both of them also carried a pathogenic truncation variant in the PKP2 gene. This variant has also been reported in three individuals affected with sudden death (PMID: 26498160, 27930701, 31970460) and in an individual affected with dilated cardiomyopathy who carried a pathogenic truncation variant in the TTN gene that could explain the observed phenotype (PMID: 36178741). This variant has been identified in 11/282620 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy Uncertain:1
- -
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
This missense variant replaces serine with phenylalanine at codon 868 of the DSC2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20400443, 30790397). Both of them also carried a pathogenic truncation variant in the PKP2 gene. This variant has also been reported in three individuals affected with sudden death (PMID: 26498160, 27930701, 31970460) and in an individual affected with dilated cardiomyopathy who carried a pathogenic truncation variant in the TTN gene that could explain the observed phenotype (PMID: 36178741). This variant has been identified in 11/282620 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at